Convergence Science Initiative – Cancer: CSI-Cancer

  • CSI Cancer is focused on improving the lives of cancer patients through scientific insights relevant to individual patients.CSI_Flower
  • CSI Cancer at USC is led by Dr. Peter Kuhn (email: kuhn42@usc.edu) and each project is led by a team comprised of patients, medical doctors, scientists and students focused on solving the clinical challenge through basic science breakthroughs that can be translated into real world solutions.

 

cancerbasesideblue (1)Basic yet critical information about most cancers and how they spread through the body just isn’t readily available. Today, CancerBase, a grassroots collaboration of patients, scientists, and social media volunteers, will go live with a way to connect patients all around the world to solve this problem, providing critical information to patients. Our goal is to bring together millions of patients to anonymously contribute the “what, when, and where” of their cancers, empowering themselves, each other, and scientists to see cancer more clearly. READ MORE>>>

CSI Cancer and the Kuhn laboratory at USC are proud to be part of CancerBase.

Recent News

The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupThursday, September 29th, 2016 at 4:31am
SXSL calls on every American to discover their own way to make a positive difference in our country while celebrating the work so many Americans have already accomplished.
We are proud to participate in Vice President Joe Biden’s Cancer Moonshot exhibit at this White House event on October 3rd.

The festival, presented in coordination with the American Film Institute (AFI), the President’s Committee on the Arts and the Humanities (PCAH), the National Park Foundation, and South by Southwest, will be streamed live at WhiteHouse.gov and Facebook.com/WhiteHouse.
3    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupThursday, September 29th, 2016 at 4:29am
The project Analytical Technologies to Objectively Measure Human Performance (ATOM-HP) will be one of the participants in the Cancer Moonshot exhibit championed by Vice President Joe Biden. #SXSL
Learn more about this project at http://kuhn.usc.edu/health-assessment/.
2    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupThursday, September 29th, 2016 at 4:20am
Wearable tech is getting smarter. A step beyond simple activity tracking, USC is showing how wearables are becoming a valuable resource in treating cancer!
4    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupThursday, September 29th, 2016 at 4:16am
On October 3rd as part of the "South by South Lawn: A White House Festival of Ideas, Art and Action" (SXSL), the Kuhn/Hicks lab will demonstrate how using wearable technology and smartphones can improve cancer treatment at the White House event #SXSL
The project is called Analytical Technologies to Objectively Measure Human Performance (ATOM-HP).
1    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupSunday, September 11th, 2016 at 8:36pm
On September 7, the Cancer Moonshot’s Blue Ribbon Panel presented its report to the National Cancer Advisory Board. The report describes a set of consequential recommendations for accelerating cancer research to achieve the ambitious goal of making a decade’s worth of cancer research progress in five years and to bring the most promising science and clinical developments to cancer patients in the near term.
The recommendations in this report represent the merger of science, technology, advocacy, social science, and big data coming together to solve cancer’s greatest challenges.

Watch videos about the Blue Ribbon Panel recommendation topics at http://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel.
1 1    View on Facebook